Assays development

Kind of assays

Fluofarma has developed a panel of cell-based tests suited to automated flow cytometry analysis. These assays, based on proprietary biosensors, tagged antibodies or quantum dots, enable the measurement of more than hundred different molecular events in living cells.

All of Fluofarma's cell-based assays can be performed in multiplexed conditions, meaning that you can simultaneously monitor several parameters at the single-cell level.

Diversity of assays

Fluofarma cell-based assays allow a high diversity of measuring:

Measure of cellular and molecular events in all the cell compartments and organelles (membrane, nucleus, cytoplasm, mitochondria...)

Analysis of various types of cell lines (cancer cells, neurons, microalgae...)

Testing of any kind of compounds like chemical entities, crude extracts, gene collections or proteins


Thanks to the creativity and the strong know-how of its scientists, Fluofarma offers you custom-made assays to fulfill your research and development needs.

Download Assays.pdf

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Cell Research.

    Read more [+]

  • Publication

    Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”

    Read more [+]

  • Press Release

    Roche adopts Fluofarma’s high-content screening platform.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".

    Read more [+]

  • ECCP 2010

    Fluofarma will be attending the European Cancer Cluster Partnering 2010 in Oslo, from September 15th to 17th.

    Read more [+]

  • BIO-Connexion Congress

    Fluofarma will be attending the Bio-Connexion Congress in Paris, from October 6th to 7th.

    Read more [+]

  • 22nd EORTC-NCI-AACR symposium

    Fluofarma will be exhibitor at the 22nd EORTC-NCI-AACR symposium in Berlin from November 16th to 19th.

    Read more [+]

Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into a multi-year agreement with Roche.
Read More



ALL NEWS